Health Care/Hospital
Telix, GMS and Monash Awarded $23M Federal Government Funding as part of $71M Australian Precision Medicine Enterprise (APME) Project
MELBOURNE, Australia, April 4, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that it is part of a $71.2 million Australian Precision Medicine Enterprise (APME) Project, which has been awarded$23 million in Federal Government grant funding under t...
2022-04-04 09:13
2860
CanSinoBIO's COVID-19 mRNA Vaccine Receives Approval of Clinical Trial Application in China
TIANJIN, April 4, 2022 /PRNewswire/ -- CanSino Biologics Inc. ("CanSinoBIO" of "the Company") (SSE: 688185, HKEX: 06185) today announced that the National Medical Products Administration ofChina ("NMPA") granted approval for the clinical trial application of its COVID-19 mRNA vaccine inChina. Pr...
2022-04-04 08:30
4857
Innovent Releases Results of a Phase 3 Clinical Study of IBI306 (PCSK-9 inhibitor) in Chinese Patients with Heterozygous Familial Hypercholesterolemia at the American College of Cardiology Annual Congress 2022
SAN FRANCISCO and SUZHOU, China, April 4, 2022 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, metabolic, autoimmune and other major dise...
2022-04-04 08:00
3250
Commercial Launch: Illuccix® Now Available to Order in the United States
MELBOURNE, Australia and INDIANAPOLIS, April 4, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) announces that its prostate cancer imaging agent, Illuccix® (kit for preparation of gallium Ga 68 gozetotide), also known as68Ga-PSMA-11 injection, is now commercially...
2022-04-04 07:06
2430
Ascletis Announces Submission of Marketing Authorization Application for Ritonavir in Hong Kong
HANGZHOU and SHAOXING, China, April 3, 2022 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672) today announces that it has submitted the marketing authorization application for ritonavir (100 mg film-coated tablet) in the Hong Kong Special Administrative Region ofthe People's Republic of China ("H...
2022-04-03 18:20
3280
Peijia Medical Announces 2021 Annual Results
Dual Engines Promote Commercialization Total Revenue Increased by 253.2% HONG KONG, April 2, 2022 /PRNewswire/ -- Peijia Medical Limited ("Peijia Medical" or the "Company", together with its subsidiaries, the "Group", stock code: 9996), a leading player in the high-growth transcatheter valve th...
2022-04-02 00:06
9844
Pharming Announces Positive Data from Phase II/III Leniolisib Trial Presented at Clinical Immunology Society 2022 Annual Meeting
LEIDEN, Netherlands, April 1, 2022 /PRNewswire/ -- Pharming Group N.V. ("Pharming" or "the Company") (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) announces new data from the pivotal Phase II/III trial of leniolisib for the treatment of activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS)...
2022-04-01 23:45
4452
REDUCE LAP-HF II ANALYSES SHOW 50% OF STUDY PATIENTS DEMONSTRATED SIGNIFICANT CLINICAL BENEFIT FROM THE CORVIA® ATRIAL SHUNT
Landmark trial advances understanding of which HFpEF patients may benefit from atrial shunt therapy TEWKSBURY, Mass., April 1, 2022 /PRNewswire/ -- Corvia Medical, Inc, a company dedicated to transforming the treatment of heart failure (HF), announced publication of analyses from its global, ...
2022-04-01 18:03
2133
Venus Medtech announces 2021 annual results: pacesetter in China and breakthrough-maker worldwide
HANGZHOU, China, April 1, 2022 /PRNewswire/ -- On March 31, 2022, Venus Medtech (Hangzhou) Inc. (2500.HK, hereinafter referred to as "Venus Medtech"), a leading provider of integrated solutions for transcatheter structural heart valvular therapies inChina, announced its annual results for the yea...
2022-04-01 10:34
2092
UMP Healthcare Expands Free Telemedicine and Drug Delivery to COVID-19 Patients
Charity Foundation Receives HK$1 million Donation from CTFE Social Solutions * * * Demand for Telemedicine Increases and Expects to be a New Trend in Medical Services Nearly 90% of Users are Willing to Recommend the Services to Relatives and Friends HONG KONG, April 1, 2022 /PRNewswire/ -- U...
2022-04-01 08:30
4198
NCCN Annual Conference Focuses on Cancer Patient Journey; with Cutting-Edge Research and Latest Evidence-Based Care Recommendations
Three-day #NCCN2022 virtual oncology conference from National Comprehensive Cancer Network includes didactic presentations, interactive discussions, and challenging case reviews. PLYMOUTH MEETING, Pa., March 31, 2022 /PRNewswire/ -- The NCCN 2022 Annual Conference brings together more than a tho...
2022-03-31 20:56
1529
HOYA Group Appoints Rainer Burkard as Global President of PENTAX Medical
TOKYO, March 31, 2022 /PRNewswire/ -- PENTAX Medical, a division of HOYA Group,
has announced the appointment ofRainer Burkard to the position of Global
President of PENTAX Lifecare Division (PENTAX Medical) as ofApril 1st, 2022.
2022-03-31 20:00
1932
Tai Chi Training Can Effectively Improve Parkinson's Disease and Mild Cognitive Impairment
HONG KONG, March 31, 2022 /PRNewswire/ -- The latest research shows that Tai Chi training is conducive to the treatment of Parkinson's disease and the prevention of Alzheimer's disease. Professor Shengdi Chen from the Neurology Department of Ruijin Hospital, Shanghai Jiao Tong University School o...
2022-03-31 18:15
3527
Brii Bio Presents New Data on BRII-835 (VIR-2218) in Chinese Patients with Chronic Hepatitis B at APASL 2022
New data demonstrate BRII-835 (VIR-2218) was well tolerated with notable
reductions in serum HBsAgobserved in the Chinese patients infected with chronic
hepatitis B
DURHAM, N.C. and BEIJING, March 31, 2022 /PRNewswire/ -- Brii Biosciences
2022-03-31 18:05
2380
Novavax Submits Request to Expand Conditional Marketing Authorization of COVID-19 Vaccine in the European Union to Adolescents (Ages 12-17)
* If granted, Nuvaxovid™ COVID-19 Vaccine (recombinant, adjuvanted) would be the first protein-based option for adolescents aged 12-17 years inEurope GAITHERSBURG, Md., March 31, 2022 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializi...
2022-03-31 18:00
2411
Growing Leaders: How VISTA Eye Specialists have gained from its Upskilling Program using Gamification.
PETALING JAYA, Malaysia, March 31, 2022 /PRNewswire/ -- Started amidst the 1st year of COVD inMalaysia in 2020, VISTA Eye Specialists (VISTA), one of the leading Eye Specialists inMalaysia since 1999, implemented an Upskilling program to help the staff take the focus away from the COVID pandemic ...
2022-03-31 17:12
1869
Airway Therapeutics Announces First Patient Dosed in Phase 1b Trial of AT-100 in Preterm Infants at Risk for Bronchopulmonary Dysplasia (BPD)
Novel preventative AT-100 offers potential to reduce incidence and severity of serious respiratory disease BPD, improving outcomes in very preterm infants MARIETTA, Ga., March 31, 2022 /PRNewswire/ -- Airway Therapeutics, Inc. (Airway), a biopharmaceutical company developing a new class of biolog...
2022-03-31 17:00
1949
JW Therapeutics Announces IND Approval for the Pivotal Clinical Trial of Carteyva® in Second-line Large B-Cell Lymphoma
SHANGHAI, March 31, 2022 /PRNewswire/ -- JW Therapeutics (HKEx: 2126), an independent, innovative biotechnology company focused on developing, manufacturing and commercializing cell immunotherapy products, announced that it has received the Investigational New Drug (IND) clearance from the Nation...
2022-03-31 12:20
2310
CStone announces first patient enrollment in the U.S. in the Phase 1 clinical trial of CS5001, a potential global best-in-class ROR1-targeting ADC
* Commencement of the first-in-human clinical trial of CS5001 marks another key milestone for CStone's Pipeline 2.0 * Global development of CS5001 is conducted in the form of a multi-regional clinical trial, with sites initiated in the US andAustralia, and an IND application accepted by the ...
2022-03-31 08:02
2500
Everest Medicines Submits New Drug Application in Hong Kong for Sacituzumab Govitecan in Second-Line Metastatic Triple-Negative Breast Cancer
SHANGHAI, March 31, 2022 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK), a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products to address critical unmet needs inAsia Pacific markets, announced today that it has submitted a New Drug Applicat...
2022-03-31 08:00
3358
Week's Top Stories
Most Reposted
Protiviti Transforms Cyber Risk Consulting with CYFIRMA's Advanced Intelligence-Led Cybersecurity
[Picked up by 324 media titles]
2024-04-15 09:00Sephora appoints Xia Ding as Managing Director of Sephora Greater China
[Picked up by 309 media titles]
2024-04-15 17:33
With unique features, Hainan TV opened "The World's Specialty" pavilion at the Expo!
[Picked up by 281 media titles]
2024-04-18 21:26
Animated Life in Yunnan
[Picked up by 278 media titles]
2024-04-18 14:00
Allianz Partners Introduces Instant Online Chat for HCF Travel Insurance Customers
[Picked up by 276 media titles]
2024-04-15 08:00
Most Read
Sephora appoints Xia Ding as Managing Director of Sephora Greater China
2024-04-15 17:33
3814
Allianz Partners Introduces Instant Online Chat for HCF Travel Insurance Customers
2024-04-15 08:00
3081
Goldpac Exhibits at InnoEx 2024
2024-04-13 10:00
2972
